StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS - Free Report) in a research note issued to investors on Saturday morning. The firm issued a hold rating on the stock.
Milestone Scientific Price Performance
Shares of NYSE MLSS traded up $0.04 during trading on Friday, hitting $0.94. 7,275 shares of the company were exchanged, compared to its average volume of 130,750. The company has a market cap of $73.29 million, a price-to-earnings ratio of -13.36 and a beta of 0.93. Milestone Scientific has a 1 year low of $0.58 and a 1 year high of $1.39. The firm's fifty day moving average price is $0.95 and its 200 day moving average price is $0.97.
Institutional Investors Weigh In On Milestone Scientific
Several institutional investors have recently made changes to their positions in the stock. XTX Topco Ltd boosted its position in shares of Milestone Scientific by 99.2% during the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock worth $32,000 after purchasing an additional 17,002 shares in the last quarter. Brookwood Investment Group LLC purchased a new stake in shares of Milestone Scientific during the 1st quarter worth $46,000. Renaissance Technologies LLC boosted its position in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock worth $121,000 after purchasing an additional 53,198 shares in the last quarter. Carnegie Investment Counsel raised its stake in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock worth $166,000 after buying an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after buying an additional 31,572 shares during the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
